Arkolith/Insider Trading/ALLO/Form 4

Messemer Deborah M.

DirectorAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Dec 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2024Sell(S)9K$2.18$20K158K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001737287-24-000081) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML